Cargando…
Reversible transition from a hypertrophic to a dilated cardiomyopathy
We report the case of a 17‐year‐old female patient with known hypertrophic cardiomyopathy and a Wolff‐Parkinson‐White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fra...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064744/ https://www.ncbi.nlm.nih.gov/pubmed/27774273 http://dx.doi.org/10.1002/ehf2.12072 |
_version_ | 1782460221074964480 |
---|---|
author | Spillmann, Frank Kühl, Uwe Van Linthout, Sophie Dominguez, Fernando Escher, Felicitas Schultheiss, Heinz‐Peter Pieske, Burkert Tschöpe, Carsten |
author_facet | Spillmann, Frank Kühl, Uwe Van Linthout, Sophie Dominguez, Fernando Escher, Felicitas Schultheiss, Heinz‐Peter Pieske, Burkert Tschöpe, Carsten |
author_sort | Spillmann, Frank |
collection | PubMed |
description | We report the case of a 17‐year‐old female patient with known hypertrophic cardiomyopathy and a Wolff‐Parkinson‐White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction. Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6 months. Non‐invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis. Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function. EMB analysis resulted in the diagnosis of a virus‐negative, active myocarditis. Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3 months after initiating therapy. In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype. This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement. |
format | Online Article Text |
id | pubmed-5064744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50647442016-10-19 Reversible transition from a hypertrophic to a dilated cardiomyopathy Spillmann, Frank Kühl, Uwe Van Linthout, Sophie Dominguez, Fernando Escher, Felicitas Schultheiss, Heinz‐Peter Pieske, Burkert Tschöpe, Carsten ESC Heart Fail Case Report We report the case of a 17‐year‐old female patient with known hypertrophic cardiomyopathy and a Wolff‐Parkinson‐White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction. Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6 months. Non‐invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis. Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function. EMB analysis resulted in the diagnosis of a virus‐negative, active myocarditis. Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3 months after initiating therapy. In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype. This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement. John Wiley and Sons Inc. 2015-12-09 /pmc/articles/PMC5064744/ /pubmed/27774273 http://dx.doi.org/10.1002/ehf2.12072 Text en © 2015 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Spillmann, Frank Kühl, Uwe Van Linthout, Sophie Dominguez, Fernando Escher, Felicitas Schultheiss, Heinz‐Peter Pieske, Burkert Tschöpe, Carsten Reversible transition from a hypertrophic to a dilated cardiomyopathy |
title | Reversible transition from a hypertrophic to a dilated cardiomyopathy |
title_full | Reversible transition from a hypertrophic to a dilated cardiomyopathy |
title_fullStr | Reversible transition from a hypertrophic to a dilated cardiomyopathy |
title_full_unstemmed | Reversible transition from a hypertrophic to a dilated cardiomyopathy |
title_short | Reversible transition from a hypertrophic to a dilated cardiomyopathy |
title_sort | reversible transition from a hypertrophic to a dilated cardiomyopathy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064744/ https://www.ncbi.nlm.nih.gov/pubmed/27774273 http://dx.doi.org/10.1002/ehf2.12072 |
work_keys_str_mv | AT spillmannfrank reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT kuhluwe reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT vanlinthoutsophie reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT dominguezfernando reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT escherfelicitas reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT schultheissheinzpeter reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT pieskeburkert reversibletransitionfromahypertrophictoadilatedcardiomyopathy AT tschopecarsten reversibletransitionfromahypertrophictoadilatedcardiomyopathy |